| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 1376494 | Bioorganic & Medicinal Chemistry Letters | 2006 | 5 Pages | 
Abstract
												We report the discovery and preliminary SAR studies of a series of structurally novel benzotriazine core based small molecules as inhibitors of Src kinase. To the best of our knowledge, benzotriazine template based compounds have not been reported as kinase inhibitors. The 3-(2-(1-pyrrolidinyl)ethoxy)phenyl analogue (43) was identified as one of the most potent inhibitors of Src kinase.
Graphical abstractWe report the SAR studies of a series of structurally novel benzotriazine analogs as inhibitors of Src. The 3-(2-(1-pyrrolidinyl)-ethoxy)phenyl analog (43) was identified as one of the most potent inhibitors.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
												
													Physical Sciences and Engineering
													Chemistry
													Organic Chemistry
												
											Authors
												Glenn Noronha, Kathy Barrett, Jianguo Cao, Elena Dneprovskaia, Richard Fine, Xianchang Gong, Colleen Gritzen, John Hood, Xinshan Kang, Boris Klebansky, G. Li, W. Liao, Dan Lohse, Chi Ching Mak, Andrew McPherson, Moorthy S.S. Palanki, Ved P. Pathak, 
											